1. Home
  2. SPRO vs AMCI Comparison

SPRO vs AMCI Comparison

Compare SPRO & AMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$2.77

Market Cap

135.5M

Sector

Health Care

ML Signal

HOLD

AMCI

AMC Robotics Corporation Common Stock

N/A

Current Price

$6.76

Market Cap

157.7M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SPRO
AMCI
Founded
2013
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
135.5M
157.7M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
SPRO
AMCI
Price
$2.77
$6.76
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
425.0K
36.0K
Earning Date
05-12-2026
04-20-2026
Dividend Yield
N/A
N/A
EPS Growth
111.81
N/A
EPS
0.15
N/A
Revenue
$66,802,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$300.00
N/A
P/E Ratio
$18.73
$33.37
Revenue Growth
39.24
N/A
52 Week Low
$0.58
$3.60
52 Week High
$3.09
$15.75

Technical Indicators

Market Signals
Indicator
SPRO
AMCI
Relative Strength Index (RSI) 58.04 53.28
Support Level $2.15 $6.15
Resistance Level $2.88 $7.39
Average True Range (ATR) 0.13 0.54
MACD 0.01 0.09
Stochastic Oscillator 64.04 56.84

Price Performance

Historical Comparison
SPRO
AMCI

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About AMCI AMC Robotics Corporation Common Stock

AMC Robotics Corp is an artificial intelligence services company that develops robotic solutions designed to support operational efficiency across sectors such as logistics and manufacturing. The company develops robotics and automation technologies designed to improve logistics operations. Its robots use sensors and visual AI to support real-time decision-making, contributing to safer and more efficient warehouse operations. It builds autonomous robots for use in logistics and warehousing.

Share on Social Networks: